ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.2% | 71.8% | 37.0% | 23.0% | 59.7% | 36.4% | 67.1% | 58.8% | 51.0% | 49.6% | 21.7% | 19.1% | 10.7% | 98.9% | 99.3% | 97.9% | 97.8% | 96.3% | 95.3% | 90.4% | 100.0% | 100.0% | |
| 3.6% | 4.8% | 9.0% | 12.3% | 53.3% | 5.3% | 57.7% | 42.0% | – | 22.6% | 18.3% | 17.1% | 8.8% | 97.4% | 95.9% | 38.2% | 93.4% | 94.3% | 92.2% | 66.2% | 3.7% | 90.9% | |
| 79.4% | 69.3% | 33.1% | 19.8% | 58.0% | 20.1% | 57.7% | 42.0% | 28.8% | 22.6% | 18.3% | 17.1% | 8.8% | 97.4% | 95.9% | 95.5% | 93.4% | 94.3% | 92.2% | 66.2% | 3.7% | 90.9% | |
| – | – | – | – | – | – | – | – | – | – | 0.1% | – | – | – | – | 0.0% | – | – | – | 0.0% | 91.3% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | 41.7% | 29.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 41.0% | 48.8% | – | 35.9% | 50.1% | 87.8% | – | – | – | – | – | – | – | – | – | |
| 9.2% | 8.6% | 16.5% | 19.0% | 7.6% | 20.4% | 42.6% | 47.5% | 48.9% | 45.3% | 17.5% | 37.5% | 50.6% | 13.8% | 15.4% | 38.6% | 61.4% | 50.4% | 150.5% | 1,420.0% | 917.7% | 325.9% | |
| 7.5% | 7.0% | 12.7% | 15.2% | 6.4% | 18.7% | 23.9% | 38.0% | 45.5% | 45.3% | 5.5% | 4.0% | 4.0% | 13.8% | 15.4% | 20.0% | 37.2% | 22.1% | 109.3% | 1,325.8% | 917.7% | 325.9% | |
| – | – | – | – | – | – | 15.8% | 25.6% | 31.6% | 30.8% | – | – | – | – | – | 8.2% | 21.3% | 1.5% | 22.2% | 137.4% | 219.1% | 19.0% | |
| 1.3% | 3.6% | 2.2% | 3.3% | 3.5% | 13.7% | 4.0% | 6.5% | 8.5% | 9.0% | – | 1.2% | – | 6.2% | 1.5% | 3.2% | 1.8% | 3.1% | 14.3% | 332.9% | 179.6% | 51.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 40.5% | 94.2% | – | – | |
| 90.8% | 91.4% | 83.5% | 81.0% | 92.4% | 79.6% | 57.4% | 52.5% | 49.6% | 53.3% | 82.5% | 62.5% | 49.4% | 86.2% | 84.6% | 61.4% | 38.6% | 49.6% | -50.5% | -1,320.0% | -817.7% | -225.9% | |
| -241.3% | -311.7% | -632.7% | -771.3% | -284.0% | -504.7% | -365.5% | -706.6% | -969.7% | -1,048.6% | -264.8% | -548.3% | -1,253.3% | -157.2% | -169.9% | -232.4% | -648.1% | -528.0% | -1,299.0% | -17,023.5% | -9,898.7% | -5,703.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.3% | 0.4% | 0.9% | 13.7% | 11.5% | 21.3% |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.